Policy Insights papers
-
Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care
JMIR EHR design paper
Status: Published
Categories
- OpenPrescribing
- Policy Insights
-
The NHS deserves better use of hospital medicines data
Hospitals Data BMJ Paper.
Status: Published
Categories
- OpenPrescribing
- Policy Insights
-
Bringing NHS data analysis into the 21st century
JRSM Paper on NHS Analytics
Categories
- Open Working
- Policy Insights
-
The poor performance of apps assessing skin cancer risk
BMJ Skin apps paper
Categories
- Policy Insights
-
Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study
Lancet FDAAA Paper
Categories
- Policy Insights
- TrialsTracker
-
Barriers to Working With National Health Service England's Open Data
JMIR Barriers paper
Categories
- Open Working
- Policy Insights
-
Why researchers should share their analytic code
BMJ Editorial
Categories
- Open Working
- Policy Insights
- Research Integrity
-
FDAAA TrialsTracker: A live informatics tool to monitor compliance with FDA requirements to report clinical trial results
FDAAA TrialsTracker Pre-Print
Status: Preprint
Categories
- Policy Insights
- TrialsTracker
-
Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? A cohort study and survey in NHS England primary care
Describing trends and geographical variation in prescribing of trimethoprim and nitrofurantoin to treat urinary tract infections
Status: Published
Categories
- OpenPrescribing
- Policy Insights
-
Too few trials or too few reported trials?
Highlighting that there is a serious ongoing issue with the results of completed trials not being reported.
Categories
- Policy Insights
- TrialsTracker
-
Why Cochrane should prioritise sharing data
Discussing Cochrane's practice on data sharing.
Categories
- Open Working
- Policy Insights
- Research Integrity
-
Noncommercial Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.
Assessing trials transparency policies from a sample of noncommercial funders
Categories
- Policy Insights
- Research Integrity
-
Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
Measuring the uptake of tamoxifen, and the alternative raloxifene, in national prescribing data sets
Status: Published
Categories
- OpenPrescribing
- Policy Insights
-
A cross-sectional study of all clinicians' conflict of interest disclosures to NHS hospital employers in England 2015-2016.
Documenting how NHS trusts in the UK record and share disclosures of conflict of interest by their employees
Categories
- Policy Insights
- Research Integrity
-
Make journals report clinical trials properly
Describing the need for better reporting of clinical trials.
Categories
- Policy Insights
- TrialsTracker
-
Fixing flaws in science must be professionalized
Discussing the need for greater transparency around data and analytics.
Categories
- Policy Insights
- Research Integrity
-
Antivirals, pandemic planning, and failure to heed calls for trial data
Editorial
Categories
- Policy Insights
- TrialsTracker
-
How medicine is broken, and how we can fix it
Editorial
Categories
- Policy Insights
- Research Integrity
-
How to get all trials reported: audit, better data, and individual accountability
Discussing the rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results
Categories
- Policy Insights
- TrialsTracker